Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
InChi: InChI=1S/C42H68N6O10/c1-29(47(5)41(53)58-42(2
is a neurokinin (NK1) receptor antagonist
GKT137831 attenuates hypoxia-induced HPASMC and HPAEC proliferation at 5 and 20 μM
that converge on phosphorylating the α-subunit of initiation factor 2 (eIF2α )
Umifenovir prevents contact between the virus and target host cells
AVL-292 Catalog No.:M11333-2 InChi: InChI=1S/C42H68N6O10/c1-29(47(5)41(53)58-42(2Spebrutinib, also known as AVL 292 or CC 292, is an orally bioavailable, selective inhibitor of Brutons agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity. Upon administration, AVL 292 targets and covalently binds to BTK, thereby preventing its activity. By irreversibly inhibiting BTK, administration of this agent may lead to an inhibition of B cell receptor (BCR) signaling and may inhibit cell proliferation of B cell